STRIDES PHARMA SCIENCE LIMITED — Share Issue/Capital Change 2023

Oct 25, 2023

==> picture [154 x 50] intentionally omitted <==

October 25, 2023

BSE Limited

Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001 Scrip code: 532531

The National Stock Exchange of India Limited Exchange Plaza, Bandra-Kurla Complex Bandra (E) Mumbai - 400 051 Scrip code: STAR

Dear Sirs,

Sub: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. SEBI/ HO/ CFD/ CFD-PoD-1/ P/ CIR/ 2023/ 123 dated July 13, 2023

This is to inform you that Management Committee of the Board of Directors of the Company in their meeting held today have allotted 11,97,510 equity shares of face value of Rs. 10/- each to M/s. Karuna Business Solutions LLP (Warrant Holder) upon conversion of equivalent number of warrants to equity shares. These shares shall rank in pari passu with the existing equity shares of the Company in all respects.

Consequent to above, paid-up share capital of the Company has increased from Rs. 90,68,28,540 consisting of 9,06,82,854 equity shares of Rs. 10/- each to Rs. 91,88,03,640 consisting of 9,18,80,364 equity shares of Rs. 10/- each.

Disclosure under Regulation 30 of SEBI Listing Regulations read with SEBI circular dated September 9, 2015, bearing reference no. CIR/CFD/CMD/4/2015 ("SEBI Circular’), read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD1/P/CIR/2023/123 dated July 13, 2023 are provided in ‘ Annexure 1’.

Request you to take the above on record.

Thanks & Regards, For Strides Pharma Science Limited,

==> picture [90 x 87] intentionally omitted <==

MANJULA Digitally signed by MANJULA RAMAMURT RAMAMURTHY Date: 2023.10.25 HY 17:58:47 +05'30' Manjula Ramamurthy Company Secretary ICSI Membership No.: A30515

Encl: As above

==> picture [500 x 48] intentionally omitted <==

==> picture [154 x 50] intentionally omitted <==

Annexure 1

Disclosure under Regulation 30 read with Schedule III to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR) and SEBI Circular bearing reference SEBI/ HO/ CFD/ CFD‐PoD‐1/ P/ CIR/ 2023/ 123 dated July 13, 2023

#	Particulars	Details
1.	Type of securities proposed to be issued	Equity Shares pursuant to conversion of Warrants
2.	Type of issuance	Preferential allotment
3.	Total number of securities proposed to be issued or the total amount for which the securities will be issued (approximately)	Allotment of 11,97,510 Equity Shares of face value of Rs. 10/‐ each upon conversion of equal number of Warrants at an issue price of Rs. 442/‐ each (inclusive of a premium of Rs. 432/- per share).
4.	Additional information in case	of Preferential Issue
i.	Names of the Investors	Karuna Business Solutions LLP
ii.	Post allotment of securities
a.	Outcome of the subscription, issue price/ allotted price (in case of convertibles)	Allotment of 11,97,510 Equity Shares of face value of Rs. 10/‐ each upon conversion of equal number of Warrants at an issue price of Rs. 442/‐ each (inclusive of a premium of Rs. 432/- per share).
b	Number of investors	One
c.	In case of convertibles – intimation on conversion of securities or on lapse of the tenure of the instruments	Allotment of 11,97,510 equity shares of face value of Rs. 10/‐ per share of the Company upon exercise of 11,97,510 warrants.

==> picture [500 x 48] intentionally omitted <==

---